Erythrophagocytosis of myeloblasts in acute myeloid leukaemia exhibiting chromosome 8p abnormality and extramedullary disease
Erythema annulare centrifugum-like mycosis fungoides after unrelated bone marrow transplantation
Fatigue in immune thrombocytopenia
Current status and future prospects for platelet function testing in the diagnosis of inherited bleeding disorders
Changing paradigms in the management of deep vein thrombosis
The clinical impact of staging bone marrow examination on treatment decisions and prognostic assessment of lymphoma patients
Outcome of patients older than 60 years with classical Hodgkin lymphoma treated with front line ABVD chemotherapy: frequent pulmonary events suggest limiting the use of bleomycin in the elderly
Prognostic value of complete remission status at end-of-treatment FDG-PET in R-CHOP-treated diffuse large B-cell lymphoma: systematic review and meta-analysis
Spectrum of adult Parvovirus B19 infection according to the underlying predisposing condition and proposals for clinical practice
Jumping translocations, a novel finding in chronic lymphocytic leukaemia
A phase-II sequential case-series study of all patients presenting to four plasma exchange centres with presumed relapsed/refractory thrombotic thrombocytopenic purpura treated with rituximab
Management of immune thrombocytopenia in adults: a population-based analysis of the French hospital discharge database from 2009 to 2012
A cross-sectional study of bleeding phenotype in haemophilia A carriers
Green neutrophil and monocyte inclusions – time to acknowledge and report
The iron chelator deferasirox affects redox signalling in haematopoietic stem/progenitor cells
Red blood cell transfusions are associated with HLA class I but not H-Y alloantibodies in children with sickle cell disease
Differential gene expression analysis in early and late erythroid progenitor cells in β-thalassaemia
Subclonality and prenatal origin of RAS mutations in KMT2A (MLL) -rearranged infant acute lymphoblastic leukaemia
MIR21 is differentially expressed in the lymphoid tissue and modulated by stromal signalling in chronic lymphocytic leukaemia
Synergistic induction of cell death in haematological malignancies by combined phosphoinositide-3-kinase and BET bromodomain inhibition
PET2-driven de-escalation therapy in 64 high-risk Hodgkin Lymphoma patients treated with escalated BEACOPP
BRAF V 600E mutations are found in Richter syndrome and may allow targeted therapy in a subset of patients
Absence of CXCR4 mutations but high incidence of double mutant in CD79A/B and MYD88 in primary central nervous system lymphoma